Updated on 15 Oct 2026, 04:41 AM IST
|
| ||||
|
| ||||
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,748.90 | -1.14 | 4,19,619.69 | 36.56 | 5.28 | 0.87 | 0.47 |
| Divi's Laboratories | 9,029.85 | -2.64 | 2,39,714.14 | 94.31 | 14.76 | 0.32 | 0.03 |
| Torrent Pharmaceuticals | 4,594.00 | -0.88 | 1,74,734.74 | 75.82 | 20.03 | 0.77 | 141.16 |
| Zydus Lifesciences | 1,124.70 | -0.69 | 1,12,189.26 | 20.74 | 4.15 | 0.09 | 14.22 |
| Cipla | 1,314.60 | -1.13 | 1,06,201.07 | 26.55 | 3.2 | 0.95 | 1.11 |
| Meeting Date | Purpose |
|---|---|
| 2026-05-21 | Audited Results |
| 2025-11-07 | Half Yearly Results |
| 2025-05-20 | Audited Results |
| 2024-11-08 | Half Yearly Results |
| 2024-05-16 | Audited Results |
Ganga Pharmaceuticals is trading at 12.50 as on Tue Sep 08 2026 10:30:02. This is 0.00% upper as compared to its previous closing price of 12.50.
The market capitalization of Ganga Pharmaceuticals is 7.39 Cr as on Tue Sep 08 2026 10:30:02.
The 52 wk high for Ganga Pharmaceuticals is 13.97 whereas the 52 wk low is 9.35
Ganga Pharmaceuticals can be analyzed on the following key metrics -
Ganga Pharmaceuticals reported a net profit of 0.10 Cr in 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.